GSK3B and amyotrophic lateral sclerosis: Considering that GSK-3β is overactivated in ALS and that it plays an important role in motoneuronal cell death, the development of new GSK-3β inhibitors might be helpful in the treatment of ALS, so there are many new GSK-3β inhibitors under development (Table 1) [48].